Need to jump-start your research?

Decision Biomarkers offers off-the-shelf chips for therapeutic research. We have built standard panels with known biomarkers to test drug candidates in such areas as Oncology, Central Nervous System Disorders, Cardiovascular Disease, and a variety of inflammatory disorders.

Using standard panels allows the testing process to get going right away as we’ve already optimized the assay and developed the working curve.

Master curves are generated from the respective means of standard curves and electronically stored in the instrument software for every given lot of biochips. No wonder test results gained from the MAX BIOCHIP™ stand up to repeated verification.

Our biochips are heads above our competitors because we pioneered advances in surface chemistry to enable protein arrays. In conjunction with one of our partners, we developed a novel surface chemistry based on thin-film technology that results in biochips with high sensitivity, broad dynamic range and excellent spot morphology.

You should also know we’re the only company out there making biochips for protein research in drug discovery trials. Every chip provides a fully validated assay. We “test drive” every one before delivery to make sure the chip meets your assay requirements.  

And remember there’s no messy lab work as our biochips contain all the necessary ingredients to run your assay. These biochips work with our AVANTRA™Q400 biomarker workstation that’s specifically built to automate the assay and expedite your work. You don’t have to spend hours preparing assays with our system.

	MAX BIOCHIP™ Data Sheet [396k]
	MAX BIOCHIP™ 8 Plex Cytokine Data Sheet [464k]